Radiation damage and recovery of plastic scintillators under ultra-high dose rate 200 MeV electrons (VHEEs) at CERN CLEAR facility

The team investigates the radiation damage and recovery of plastic scintillators under ultra-high dose rate (UHDR) conditions using 200 MeV electrons at the CERN CLEAR facility (VHEEs). Their findings highlight the challenges of accurate dosimetry in UHDR radiotherapy and explores the potential of plastic scintillation detectors (PSDs) for research and clinical applications using this innovative beam conditions and modality.

HYPERSCINT, developed by Medscint, is uniquely positioned to address these challenges with its hyperspectral technology, enabling precise differentiation between scintillation and Cherenkov emissions. This innovation enhances dosimetry accuracy, making HYPERSCINT a valuable tool for advancing UHDR radiotherapy research and clinical implementation, including VHEEs.

Physics in Medicine & Biology
Cloé Giguère (1,2), Alexander Hart (3), Joseph Bateman (4), Pierre Korysko (4,5), Wilfrid Farabolini (5), Yoan LeChasseur (6), Magdalena Bazalova-Carter (3), Luc Beaulieu (1,2) | 1. Département de Physique, de Génie Physique et d’Optique et Centre de Recherche sur le Cancer, Université Laval – CANADA, 2. Département de Radio-Oncologie et Axe Oncologie du CRCHU de Québec, CHU de Québec, Université Laval – CANADA, 3. Department of Physics and Astronomy, University of Victoria – CANADA, 4. Department of Physics, University of Oxford – UK, 5. CERN – SWITZERLAND, 6. Medscint – CANADA

Field output correction factors using a fully characterized plastic scintillation detector (HYPERSCINT)

As small fields become increasingly important in radiation therapy, accurate dosimetry is essential for ensuring precise dose calculation and treatment optimization. Despite the availability of small volume detectors, small field dosimetry remains challenging. The new plastic scintillation detector (PSD) from the HYPERCINT RP-200 platform from Medscint offers a promising solution with minimal correction requirements for small field measurements.

This study focused on characterizing the field output correction factors of the PSD across a wide range of field sizes and demonstrating its potential for determining correction factors for other small field detectors. Monte Carlo simulations and experimental comparisons were used to assess the system’s performance. The PSD exhibited near-unity correction factors (1.002 to 0.999) across field sizes between 0.6×0.6 cm² and 30×30 cm², with an impressive total uncertainty of 0.5%.

The PSD is shown to be a highly accurate and reliable detector for small field dosimetry, and it can also be used to determine correction factors for other dosimeters with great precision.

MEDICAL PHYSICS (AAPM)
Luc Gingras (1,2), Yunuen Cervantes (1,2,3), Frederic Beaulieu (1,2), Magali Besnier (1,2), Benjamin Coté (4), Simon Lambert-Girard (4), Danahé LeBlanc (4), Yoan LeChasseur (4), François Therriault-Proulx (4), Luc Beaulieu (1,2,3), Louis Archambault (1,2,3) | 1. CHU de Québec–Université Laval, Québec – Canada, 2. Centre de recherche du CHU de Québec, Québec – Canada, 3. Université Laval, Québec – Canada, 4. Medscint, Québec – Canada

Radioluminescence-based fibre-optic dosimeters in radiotherapy: a review (incl. HYPERSCINT)

In their comprehensive review, Veronese et al. examine the evolution and clinical application of radioluminescence-based fiber-optic dosimeters (FODs) in radiotherapy. These dosimeters have become essential tools in modern radiotherapy due to their capability for real-time, high-resolution dose measurements with minimal perturbation of the radiation field.

The authors discuss a wide range of scintillating materials, their properties, and dosimetric performance. They provide a thorough comparison of various solutions for addressing the stem-effect, a critical issue in fiber-optic dosimetry. Solutions reviewed include the hyperspectral approach (utilized by Medscint’s HYPERSCINT system), twin-fiber subtraction, optical filtering, dual-channel spectral discrimination, temporal gating, air-core light guides, and real-time Optically Stimulated Luminescence (rtOSL). Notably, the hyperspectral technology employed by HYPERSCINT represents a major advancement, effectively overcoming many limitations of other approaches by offering superior accuracy, simplified calibration procedures, and enhanced robustness, particularly valuable in complex clinical scenarios.

The review also emphasizes the growing adoption and diverse clinical applications of FODs, highlighting their significant role in improving treatment precision and patient safety. Clinical applications addressed in the review include small-field dosimetry, brachytherapy and in vivo dosimetry; advanced radiotherapy modalities such as intensity-modulated radiation therapy (IMRT), magnetic resonance-guided radiotherapy (MRgRT), hadron and proton therapies; and finally a special attention to MRI-Linac dosimetry and ultra-high dose rate (UHDR) or FLASH radiotherapy.

Radiation Measurements
Ivan Veronese (1), Claus E. Andersen (2), Enbang Li (3), Levi Madden (4), Alexandre M.C. Santos (5, 6, 7) | Department of Physics, University of Milan and National Institute for Nuclear Physics, Milano Unit, Italy, Department of Health Technology, Technical University of Denmark, Denmark, School of Physics, Faculty of Engineering and Information Sciences, University of Wollongong, Australia, Northern Sydney Cancer Centre, Royal North Shore Hospital, Australia, Australian Bragg Centre for Proton Therapy and Research, Australia, Radiation Oncology, Central Adelaide Local Heath Network, Australia, School of Physics, Chemistry and Earth Sciences, The University of Adelaide, Australia

Comprehensive investigation of HYPERSCINT RP-FLASH scintillator for electron FLASH research

This paper presents a comprehensive investigation of the HYPERSCINT RP-FLASH scintillator, designed for electron FLASH research. The study evaluates its performance in ultra-high dose rate (UHDR) electron beam dosimetry, with a focus on dose-rate independence, fast response times, and millisecond-resolved measurements. The scintillator system demonstrated high accuracy, minimal dependence on beam parameters, and effective calibration for clinical and research applications.

ARXIF Pre-publication
Lixiang Guo (1), Banghao Zhou (1), Yi-Chun Tsai (1), Kai Jiang (2), Viktor Iakovenko (2), Ken Kang-Hsin Wang (1) | 1. BIRTLab – University of Texas Southwestern Medical Center, Dallas, Texas, USA, 2. Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

High-throughput, low-cost FLASH: irradiation of Drosophila melanogaster with low-Energy X-rays using time structures spanning ConvDR and UHDR

This article explores the potential of using low-energy X-rays to deliver ultrahigh dose-rate (UHDR) FLASH radiotherapy using Drosophila melanogaster as a model. For this they have compared the effects of UHDR (210 Gy/s) and conventional dose rates (0.2–0.4 Gy/s) on the eclosion and lifespan of fly larvae. The results showed that larvae treated with UHDR had higher survival rates and longer lifespans, particularly at intermediate doses, indicating a normal tissue-sparing FLASH effect.

The Medscint scintillation dosimetry detector was used to measure the response to X-rays at a very high sampling rate to confirm the time structure of the delivered radiation (i.e. the pulse width and inter-pulse spacing). Along with film measurements, they also confirmed that the doses delivered with UHDR and CONV agreed within 0.1%.

Journal of Radiation Research
Alexander Hart (1), Jan P Dudzic (1), Jameson W Clarke (1), Jonathan Eby (2), Steve J Perlman (1), Magdalena Bazalova-Carter (1) | 1. University of Victoria, BC – CANADA, 2. University of Toronto, ON – CANADA